November 17, 2005: Syndicating the Deal

November 17, 2005

in Business,Events,Investing

David Van Avermaete, CEO of “VeraLight”: and Mike Connolly, Principal with “vSpring Capital”:

About the Presenters:
David Van Avermaete, VeraLight CEO, has 22 years of experience in the diabetes field
with specific expertise in home blood glucose monitoring and medical diagnostics. He is
a former US president of the LifeScan division of Johnson & Johnson, who during his 13
year tenure grew annual sales from under $100 million to over $1.0 billion.

Mike Connolly runs the NM offices for vSpring Capital, an early-stage venture
investment firm. He previously served as technology commercialization executive at Los
Alamos National Lab. Before relocating from Silicon Valley, Mike cofounded 7
biomedical companies, including Novacept (acquired for $325M) and Cohesion
(acquired for $40M). Y

Share This Post!
  • Facebook
  • Twitter
  • LinkedIn
  • Google Bookmarks

Previous post:

Next post: